Characterization of the B-cell inhibitory protein factor in Ixodes ricinus tick saliva: a potential role in enhanced Borrelia burgdoferi transmission

Immunology. 2004 Nov;113(3):401-8. doi: 10.1111/j.1365-2567.2004.01975.x.

Abstract

We recently described the inhibition of host B lymphocytes by Ixodes ricinus tick saliva. In this study, we characterized the factor responsible for this activity and examined the modulation of lipopolysaccharide (LPS)- and Borrelia burgdorferi outer surface protein (Osp)-induced proliferation of naive murine B lymphocytes by an enriched fraction of this factor. The B-lymphocyte inhibitory activity was destroyed by trypsin treatment, indicating that a proteinaceous factor was responsible for this activity. The removal of glutathione-S-transferase (GST) from tick salivary glands extracts (SGE) showed that this B-cell inhibitory protein (BIP) was not a GST. Gel filtration liquid chromatography indicated that BIP has a native molecular weight of approximately 18,000. An enrichment protocol, using a combination of anion-exchange and reverse-phase liquid chromatography, was established. BIP-enriched fractions did not suppress T-cell proliferation. Delayed addition of BIP-enriched fractions, up to 7 hr after LPS addition, inhibited the proliferation of isolated B cells. BIP-enriched fractions dramatically inhibited both OspA- and OspC-induced proliferation of isolated B cells. These results strongly suggest that BIP may facilitate B. burgdorferi transmission by preventing B-cell activation, and also highlights the potential of BIP as a therapeutic agent in B-cell maladies.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antigens, Bacterial
  • Antigens, Surface
  • B-Lymphocytes / drug effects
  • B-Lymphocytes / immunology
  • Bacterial Outer Membrane Proteins / antagonists & inhibitors
  • Bacterial Vaccines
  • Borrelia burgdorferi*
  • Cell Division / drug effects
  • Cell Division / immunology
  • Concanavalin A / immunology
  • Female
  • Immune Tolerance / drug effects
  • Immune Tolerance / immunology
  • Ixodes / immunology*
  • Lipopolysaccharides / immunology
  • Lipoproteins / antagonists & inhibitors
  • Lyme Disease / immunology
  • Lyme Disease / transmission*
  • Lymphocyte Activation / drug effects
  • Lymphokines / chemistry
  • Lymphokines / immunology
  • Lymphokines / pharmacology*
  • Molecular Weight
  • Saliva / immunology*
  • Spleen / immunology

Substances

  • Antigens, Bacterial
  • Antigens, Surface
  • Bacterial Outer Membrane Proteins
  • Bacterial Vaccines
  • Lipopolysaccharides
  • Lipoproteins
  • Lymphokines
  • OspA protein
  • OspC protein
  • Concanavalin A